Thursday, September 25, 2014

Sam Waksal’s New Biotech Venture Tests Investor Forgiveness by ROBERT CYRAN



By ROBERT CYRAN


The former ImClone boss who went to prison for an insider trading scandal follows others given second-chances like Donald Trump and John Meriwether, of Long-Term Capital Management.


Published: September 25, 2014 at 4:00AM


from NYT Business Day http://ift.tt/YdFizY






from WordPress http://ift.tt/1subuwG

via Hadi Aboukhater

No comments:

Post a Comment